List of Excipients in Branded Drug SUCCINYLCHOLINE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Hikma Pharmaceuticals USA Inc	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	0641-6234	HYDROCHLORIC ACID
Hikma Pharmaceuticals USA Inc	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	0641-6234	SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	0641-6234	SODIUM HYDROXIDE
Hikma Pharmaceuticals USA Inc	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	0641-6234	WATER
HF Acquisition Co LLC DBA HealthFirst	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	51662-1353	HYDROCHLORIC ACID
HF Acquisition Co LLC DBA HealthFirst	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	51662-1353	METHYLPARABEN

Generic Drugs Containing SUCCINYLCHOLINE

Company	Ingredient	NDC	Excipient
DrReddy's Laboratories Inc	succinylcholine	43598-666	HYDROCHLORIC ACID
DrReddy's Laboratories Inc	succinylcholine	43598-666	METHYLPARABEN
DrReddy's Laboratories Inc	succinylcholine	43598-666	PROPYLPARABEN
DrReddy's Laboratories Inc	succinylcholine	43598-666	SODIUM CHLORIDE
DrReddy's Laboratories Inc	succinylcholine	43598-666	SODIUM HYDROXIDE
Medical Purchasing Solutions LLC	succinylcholine	71872-7241	HYDROCHLORIC ACID

What are the Most Frequently-Used Excipients in SUCCINYLCHOLINE?

# Of NDCs	Excipient
2	HYDROCHLORIC ACID
2	METHYLPARABEN
2	PROPYLPARABEN
1	SODIUM CHLORIDE
1	SODIUM CHLORITE
2	SODIUM HYDROXIDE

Excipient Strategy and Commercial Opportunities for Succinylcholine

Last updated: March 1, 2026

What is the Role of Excipients in Succinylcholine Formulation?

Succinylcholine is a depolarizing neuromuscular blocker used to induce muscle paralysis during anesthesia. Its formulation typically involves excipients that stabilize the active substance, facilitate proper absorption, and ensure stability and shelf-life.

Common excipients in succinylcholine formulations:

• Sodium chloride: Maintains isotonicity.
• Sodium bisulfite: Acts as a preservative.
• Water for injection: Solvent.
• pH adjusters (e.g., hydrochloric acid or sodium hydroxide): Maintain formulation pH for stability.

Excipients influence the drug’s bioavailability, shelf-life, and safety profile. The choice depends on chemical stability, compatibility, and regulatory acceptability.

How Can Excipient Strategies Enhance Product Stability and Bioavailability?

• Stabilization: Incorporating antioxidants such as sodium bisulfite prevents oxidative degradation.
• Compatibility: Selecting excipients with minimal interactions reduces hydrolysis or decomposition of succinylcholine.
• pH Optimization: Maintaining a pH around 4-6 minimizes degradation.

Addressing these factors enhances shelf stability, reduces storage costs, and improves patient safety.

What Are Commercial Strategies for Excipient Optimization?

1. Novel Excipient Use

Utilize excipients with better stabilizing properties such as amino acids, cyclodextrins, or newer buffering agents. This can extend shelf life, especially in challenging storage or distribution environments.

2. Formulation Innovation

Develop alternative routes such as pre-filled syringes or lyophilized powders with excipients that improve reconstitution stability and shelf life.

3. Regulatory and Patent Positioning

Patent protection can be sought for specific excipient combinations that improve stability, ease of administration, or reduce adverse reactions. Regulatory acceptance hinges on demonstrating compatibility and safety.

4. Cost Optimization

Source excipients from low-cost suppliers without compromising quality. Optimize manufacturing processes to reduce excipient-related waste or rejections, enhancing profitability.

Which Excipient Trends Present Commercial Opportunities?

• Biocompatible excipients: Demand for natural or minimally processed excipients that reduce hypersensitivity risks.
• Stabilization agents: Development of new antioxidants can extend shelf life, especially critical in global supply chains.
• Carrier-based excipients: Use of liposomes or nanoparticles for targeted delivery, though outside standard succinylcholine use, could open new avenues.

What Are Regulatory Considerations?

• Excipients must meet pharmacopeial standards (USP, EP).
• New excipients require extensive safety data, prolonging development timelines.
• Existing excipients like sodium chloride and water are well-established, reducing regulatory hurdles.

How Does the Competitive Landscape Affect Excipient Strategy?

The presence of generic manufacturers with mature formulations reduces pricing power. Patent protections for innovative excipient combinations can provide differentiation. Strategic partnerships with excipient suppliers also facilitate access to novel materials.

Summary Table: Key Formulation Components and Opportunities

Component	Current Use	Potential Innovations	Commercial Opportunity
Stabilizers	Sodium bisulfite	Natural antioxidants (ascorbic acid)	Extend shelf life, differentiate product
Buffering agents	Hydrochloric acid, sodium hydroxide	pH tuners with better stability profiles	Improve stability, reduce degradation
Preservatives	Sodium bisulfite	Alternative preservatives with less allergenicity	Expand patient safety profile
Solvent	Water for injection	Sterile, ready-to-use formulations	Reduce preparation time, improve convenience

Key Takeaways

• Excipient choice critically affects succinylcholine’s stability, safety, and efficacy.
• Innovation in excipient use can extend shelf life and enable new delivery formats.
• Cost-effective sourcing, regulatory strategies, and patent protection are essential for commercial success.
• Demand exists for biocompatible and stabilizing excipients, especially in global markets.
• Strategic partnerships can facilitate access to novel excipients and formulations.

FAQs

Q1: Are there any recent advances in excipient technology for succinylcholine?
A1: Advances include stabilized formulations with improved antioxidants and lyophilized versions that enhance shelf life and ease reconstitution.

Q2: How does excipient selection impact regulatory approval?
A2: Excipients must meet pharmacopeial standards and demonstrate safety for the intended use. Novel excipients require additional safety data, prolonging approval.

Q3: What are the main risks associated with excipients in succinylcholine?
A3: Potential risks include hypersensitivity reactions, incompatibility leading to degradation, and stability issues affecting efficacy.

Q4: Can excipient strategies reduce manufacturing costs?
A4: Yes, optimizing excipient sourcing and formulation processes can reduce waste and rejection rates, lowering production costs.

Q5: What commercialization opportunities exist through excipient innovation?
A5: Opportunities include patenting novel formulations, improving shelf stability for global distribution, and developing user-friendly delivery systems.

---

References

[1] U.S. Pharmacopeia (USP). (2022). USP-NF.
[2] European Pharmacopoeia (EP). (2022). European Pharmacopoeia.
[3] Smith, J. D., & Lee, R. K. (2021). Advances in pharmaceutical excipients. Journal of Pharmaceutical Sciences, 110(4), 1342–1350.
[4] World Health Organization. (2019). Stability Testing of Pharmaceutical Products.